Pharmaceutical care services and results in project ImPACT: hyperlipidemia

J Am Pharm Assoc (Wash). 2000 Mar-Apr;40(2):157-65. doi: 10.1016/s1086-5802(16)31059-2.


Objective: To demonstrate that pharmacists, working collaboratively with patients and physicians and having immediate access to objective point-of-care patient data, promote patient persistence and compliance with prescribed dyslipidemic therapy that enables patients to achieve their National Cholesterol Education Program (NCEP) goals.

Design: Observational study.

Participants: 26 community-based ambulatory care pharmacies: independent, chain-professional, chain-grocery store, home health/home infusion, clinic, health maintenance organization/managed care.

Main outcome measures: Rates of patient persistence and compliance with medication therapy and achievement of target therapeutic goals.

Results: In a population of 397 patients over an average period of 24.6 months, observed rates for persistence and compliance with medication therapy were 93.6% and 90.1%, respectively, and 62.5% of patients had reached and were maintained at their NCEP lipid goal at the end of the project.

Conclusion: Working collaboratively with patients, physicians, and other health care providers, pharmacists who have ready access to objective clinical data, and who have the necessary knowledge, skills, and resources, can provide an advanced level of care that results in successful management of dyslipidemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cholesterol / blood
  • Community Pharmacy Services / organization & administration*
  • Female
  • Health Education / methods*
  • Humans
  • Hyperlipidemias / drug therapy*
  • Hypolipidemic Agents / therapeutic use*
  • Interprofessional Relations
  • Male
  • Middle Aged
  • Outcome and Process Assessment, Health Care
  • Patient Compliance*
  • Point-of-Care Systems
  • Quality Control
  • United States


  • Hypolipidemic Agents
  • Cholesterol